209 related articles for article (PubMed ID: 16440741)
1. [Triple secondary malignancy of gingiva, palate and esophagus after an allogeneic bone marrow transplantation for cutaneous T-cell lymphoma].
Koharazawa H; Yamaji S; Takasaki H; Takabayashi M; Fujimaki K; Taguchi J; Kanamori H; Ishigatsubo Y
Rinsho Ketsueki; 2005 Jul; 46(7):496-500. PubMed ID: 16440741
[TBL] [Abstract][Full Text] [Related]
2. Anaplastic squamous cell carcinoma (SCC) in a patient with chronic cutaneous graft-versus-host disease (GVHD).
Gmeinhart B; Hinterberger W; Greinix HT; Rabitsch W; Kirnbauer R; Reiter E; Volc-Platzer B
Bone Marrow Transplant; 1999 Jun; 23(11):1197-9. PubMed ID: 10382961
[TBL] [Abstract][Full Text] [Related]
3. Squamous cell carcinoma of the oral cavity associated with graft versus host disease: report of a case and review of the literature.
Demarosi F; Soligo D; Lodi G; Moneghini L; Sardella A; Carrassi A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Jul; 100(1):63-9. PubMed ID: 15953918
[TBL] [Abstract][Full Text] [Related]
4. Esophageal squamous cell carcinoma developed 11 years after allogeneic bone marrow transplantation for acute lymphatic leukemia.
Miyawaki Y; Imoto I; Tokairin Y; Kawada K; Nakajima Y; Nishikage T; Nagai K; Kajiwara M; Inazawa J; Kawano T
Jpn J Clin Oncol; 2013 Jan; 43(1):69-73. PubMed ID: 23225908
[TBL] [Abstract][Full Text] [Related]
5. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation.
Licata AG; Wilson LD; Braverman IM; Feldman AM; Kacinski BM
Arch Dermatol; 1995 Apr; 131(4):432-5. PubMed ID: 7726585
[TBL] [Abstract][Full Text] [Related]
6. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
7. [Nephrotic syndrome related to chronic graft versus host disease after allogeneic bone marrow transplantation in a patient with malignant lymphoma].
Haseyama K; Watanabe J; Oda T; Katoh S; Suzuki N; Kudoh T; Chiba S
Rinsho Ketsueki; 1996 Dec; 37(12):1383-8. PubMed ID: 8997126
[TBL] [Abstract][Full Text] [Related]
8. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y;
Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of secondary malignancies in adults after allogeneic bone marrow transplantation.
Hasegawa W; Pond GR; Rifkind JT; Messner HA; Lau A; Daly AS; Kiss TL; Kotchetkova N; Galal A; Lipton JH
Bone Marrow Transplant; 2005 Jan; 35(1):51-5. PubMed ID: 15516939
[TBL] [Abstract][Full Text] [Related]
10. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
[TBL] [Abstract][Full Text] [Related]
11. Squamous cell carcinoma of the tongue complicating chronic oral mucosal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Szeto CH; Shek TW; Lie AK; Au WY; Yuen AP; Kwong YL
Am J Hematol; 2004 Oct; 77(2):200-2. PubMed ID: 15389910
[TBL] [Abstract][Full Text] [Related]
12. [A case with myositis as a manifestation of chronic graft-versus-host-disease (GVHD) with severe muscle swelling developed after aggressive muscular exercise].
Kano S; Shimizu J; Mikata T; Shinoe T; Ota H; Komeno Y; Ogawa S; Hirai H; Kanazawa I
Rinsho Shinkeigaku; 2003 Mar; 43(3):93-7. PubMed ID: 12820556
[TBL] [Abstract][Full Text] [Related]
13. [Secondary eosinophilia in a patient with hypereosinophilic syndrome after allogeneic bone marrow transplantation from a sibling donor].
Ito C; Tsuboi K; Yoshiba F; Kubota N; Tazume K; Oki M; Tsuchiya T; Ohmachi K; Kikuchi A; Shimakura Y; Ando K; Kishi K; Yonekura S; Hotta T
Rinsho Ketsueki; 2001 Jun; 42(6):496-501. PubMed ID: 11505529
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy.
Yakoub-Agha I; Mesnil F; Kuentz M; Boiron JM; Ifrah N; Milpied N; Chehata S; Esperou H; Vernant JP; Michallet M; Buzyn A; Gratecos N; Cahn JY; Bourhis JH; Chir Z; Raffoux C; Socié G; Golmard JL; Jouet JP;
J Clin Oncol; 2006 Dec; 24(36):5695-702. PubMed ID: 17116940
[TBL] [Abstract][Full Text] [Related]
15. Multiple eccrine poromas in the setting of total body irradiation and immunosuppression.
Mahlberg MJ; McGinnis KS; Draft KS; Fakharzadeh SS
J Am Acad Dermatol; 2006 Aug; 55(2 Suppl):S46-9. PubMed ID: 16843124
[TBL] [Abstract][Full Text] [Related]
16. Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation.
Kako S; Izutsu K; Oshima K; Sato H; Kanda Y; Motokura T; Chiba S; Kurokawa M
Am J Hematol; 2007 Oct; 82(10):937-9. PubMed ID: 17663389
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of allogeneic bone marrow transplantation for 108 adult patients with acute lymphoblastic leukemia: favorable outcome with BMT at first remission and HLA-matched unrelated donor.
Chim CS; Lie AK; Liang R; Au WY; Kwong YL
Bone Marrow Transplant; 2007 Aug; 40(4):339-47. PubMed ID: 17572712
[TBL] [Abstract][Full Text] [Related]
18. Peritransplant use of ultraviolet-B irradiation (UV-B) therapy is detrimental to allogeneic stem cell transplantation outcome.
Yüksel M; Baron E; Camouse M; Cooper BW; Lazarus HM; Gerson SL; Laughlin MJ; Cooper KD; Gilliam A; Fu P; Stevens S; Koç ON
Biol Blood Marrow Transplant; 2006 Jun; 12(6):665-71. PubMed ID: 16737940
[TBL] [Abstract][Full Text] [Related]
19. Chronic demyelinating polyneuropathy in graft-versus-host disease following allogeneic bone marrow transplantation.
Nagashima T; Sato F; Chuma T; Mano Y; Sasaki I; Mori M; Higa T; Masauji N; Kasai M; Orba Y; Shinohara T; Nagashima K
Neuropathology; 2002 Mar; 22(1):1-8. PubMed ID: 12030409
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic bone marrow transplantation for hepatocellular carcinoma: hepatocyte growth factor suppresses graft-vs.-host disease.
Yoshida Y; Hirano T; Son G; Iimuro Y; Imado T; Iwasaki T; Fujimoto J
Am J Physiol Gastrointest Liver Physiol; 2007 Dec; 293(6):G1114-23. PubMed ID: 17761834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
